138900-27-3

Basic information

• Product Name: 5-CHLORO-1-(4-FLUORO-PHENYL)-3-PIPERIDIN-4-YL-1H-INDOLE
• Synonyms: 5-CHLORO-1-(4-FLUORO-PHENYL)-3-PIPERIDIN-4-YL-1H-INDOLE;5-Chloro-1-(4-fluorophenyl)-3-(4-piperidinyl)-1H-indole
• CAS NO: 138900-27-3
• Molecular Formula: C₁₉H₁₈ClFN₂
• Molecular Weight: 328.8110232
• Mol File: 138900-27-3.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 473℃
• Flash Point: 240℃
• Appearance: /
• Density: 1.30
• Storage Temp.: 2-8°C(protect from light)
• CAS DataBase Reference: 5-CHLORO-1-(4-FLUORO-PHENYL)-3-PIPERIDIN-4-YL-1H-INDOLE(CAS DataBase Reference)
• NIST Chemistry Reference: 5-CHLORO-1-(4-FLUORO-PHENYL)-3-PIPERIDIN-4-YL-1H-INDOLE(138900-27-3)
• EPA Substance Registry System: 5-CHLORO-1-(4-FLUORO-PHENYL)-3-PIPERIDIN-4-YL-1H-INDOLE(138900-27-3)

Safety Data

• Hazardous Substances Data: 138900-27-3(Hazardous Substances Data)

Usage

General Description

5-CHLORO-1-(4-FLUORO-PHENYL)-3-PIPERIDIN-4-YL-1H-INDOLE, also known as ML355, is a chemical compound that belongs to the class of indole-containing compounds. It is a potent and selective inhibitor of the enzyme type 2 cannabinoid receptor (CB2). 5-CHLORO-1-(4-FLUORO-PHENYL)-3-PIPERIDIN-4-YL-1H-INDOLE has shown promising effects in preclinical studies for its potential therapeutic applications in the treatment of various diseases, including inflammatory and neuropathic pain, as well as neurodegenerative disorders. Its unique chemical structure and targeted activity make it a valuable candidate for further research and development in the field of medicinal chemistry and drug discovery.

Upstream product

• 138900-12-6 methyl 5-chloro-1-(4-fluorophenyl)-3-hydroxy-1H-indol-2-carboxylate 
• 948553-95-5 5-Chloro-1-(4-fluoro-phenyl)-2,3-dihydro-1H-indol-3-ol 
• 170232-17-4 5-chloro-2,3-dihydro-1-(4-fluorophenyl)-1H-indol-3-one 
• 41979-39-9 4-piperidone hydrochloride 
• 106516-07-8 5-chloro-1-(4-fluorophenyl)-3-(1,2,3,6-tetrahydropyridin-4-yl)indole 
• 138900-22-8 1-(4-fluorophenyl)-5-chloroindole 

Downstream Products

• 106516-24-9 Sertindole 
• 139718-44-8 3-[1-(2-aminoethyl)piperidin-4-yl]-5-chloro-1-(4-fluorophenyl)-1H-indole 
• 769089-25-0 1-(4-fluorophenyl)-3-(4-piperdinyl)-1H-indole 
• 106516-21-6 Lu 23-086 
• 168274-67-7 1-[2-[4-[5-Chloro-1-(4-fluorophenyl)-1H-indol-3-yl]piperidin-1-yl]ethyl]-4,4,5,5-tetradeuteroimidazolidin-2-one 
• 138900-52-4 1-(2-{4-[5-Chloro-1-(4-fluoro-phenyl)-1H-indol-3-yl]-piperidin-1-yl}-ethyl)-3-phenyl-imidazolidin-2-one 
• 138900-46-6 1-(2-{4-[5-Chloro-1-(4-fluoro-phenyl)-1H-indol-3-yl]-piperidin-1-yl}-ethyl)-3-methyl-imidazolidin-2-one 
• 138900-48-8 1-(2-{4-[5-Chloro-1-(4-fluoro-phenyl)-1H-indol-3-yl]-piperidin-1-yl}-ethyl)-3-isopropyl-imidazolidin-2-one 
• 138900-50-2 1-(2-{4-[5-Chloro-1-(4-fluoro-phenyl)-1H-indol-3-yl]-piperidin-1-yl}-ethyl)-3-cyclopentyl-imidazolidin-2-one 
• 138900-44-4 1-(6-{4-[5-Chloro-1-(4-fluoro-phenyl)-1H-indol-3-yl]-piperidin-1-yl}-hexyl)-imidazolidin-2-one 
• 138900-42-2 1-(5-{4-[5-Chloro-1-(4-fluoro-phenyl)-1H-indol-3-yl]-piperidin-1-yl}-pentyl)-imidazolidin-2-one 
• 138900-40-0 1-(4-{4-[5-Chloro-1-(4-fluoro-phenyl)-1H-indol-3-yl]-piperidin-1-yl}-butyl)-imidazolidin-2-one 
• 138900-38-6 1-(3-{4-[5-Chloro-1-(4-fluoro-phenyl)-1H-indol-3-yl]-piperidin-1-yl}-propyl)-imidazolidin-2-one 

Relevant articles and documents

Noncataleptogenic, centrally acting dopamine D-2 and serotonin 5-HT2 antagonists within a series of 3-substituted 1-(4-fluorophenyl)-1H-indoles

A series of 1-(4-fluorophenyl)-1H-indoles substituted at the 3-position with 1-piperazinyl, 1,2,3,6-tetrahydro-4-pyridinyl, and 4-piperidinyl was synthesized. Within all three subseries potent dopamine D-2 and serotonin 5- HT2 receptor affinity was found in ligand binding studies. Quipazine-induced head twitches in rats were inhibited by most derivatives as a measure of central 5-HT2 receptor antagonism. Piperazinyl and tetrahydropyridyl indoles were cataleptogenic, while piperidyl substituted indoles surprisingly were found to be noncataleptogenic or only weakly cataleptogenic. Noncataleptogenic piperidyl derivatives also failed to block dopaminergic- mediated stereotypies, that is methyl phenidate-induced gnawing behavior in mice. These profiles resemble that of the atypical neuroleptic clozapine. 1- Ethyl-2-imidazolidinone was found to be the optimal substituent of the basic nitrogen atom in order to avoid catalepsy. The atypical neuroleptic 1-[2-[4- [5-chloro-1-(4-fluorophenyl)-1H-indol-3-yl]-1-piperidinyl]ethyl]-2- imidazolidinone (sertindole, compound 14c) was selected for further development as a result of these structure/activity studies.